Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
T cells made 100 times more potent at targeting cancer cells
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine, USA, may have found a…
Chronic jet lag leads to human liver cancer in a mouse model
When asked about what could cause cancer, people most likely think of chemicals like tobacco…
Brain protein’s virus-like structure may help explain cancer-induced memory loss
In a rare but serious complication of cancer, the body’s own immune system can start…
ESMO 2022: Scientists discover how air pollution may trigger lung cancer in never-smokers
- Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases
- The structure of protein RAF1 revealed: a key step in the development of new drugs against lung cancer
- Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases
How does cancer develop resistance to treatment?
Cancer cells can turn on error-prone DNA copy pathways to adapt to cancer treatment, a breakthrough study published in the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.